These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1642562)

  • 1. Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine.
    Erturk M; Hill TJ; Shimeld C; Jennings R
    Arch Virol; 1992; 125(1-4):87-101. PubMed ID: 1642562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems.
    Mohamedi SA; Brewer JM; Alexander J; Heath AW; Jennings R
    Vaccine; 2000 Apr; 18(20):2083-94. PubMed ID: 10715522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2 ISCOMs in mice; cytokine profiles, antibody responses and protection.
    Mohamedi SA; Heath AW; Jennings R
    Antiviral Res; 2001 Feb; 49(2):83-99. PubMed ID: 11248361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses and protection in mice immunized with herpes simplex virus type 1 antigen immune-stimulating complex preparations.
    Ertürk M; Jennings R; Hockley D; Potter CW
    J Gen Virol; 1989 Aug; 70 ( Pt 8)():2149-55. PubMed ID: 2769234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of influenza and HSV-1 mixed antigen ISCOMs in mice.
    Ghazi HO; Erturk M; Stannard LM; Faulkner M; Potter CW; Jennings R
    Arch Virol; 1995; 140(6):1015-31. PubMed ID: 7611875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems.
    Hassan Y; Brewer JM; Alexander J; Jennings R
    Vaccine; 1996 Dec; 14(17-18):1581-9. PubMed ID: 9032885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific and nonspecific immune stimulation of MHC-II-deficient mice results in chronic HSV-1 infection of the trigeminal ganglia following ocular challenge.
    Ghiasi H; Perng GC; Hofman FM; Cai S; Nesburn AB; Wechsler SL
    Virology; 1999 Jun; 258(2):208-16. PubMed ID: 10366558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
    Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs.
    Simms JR; Heath AW; Jennings R
    J Infect Dis; 2000 Apr; 181(4):1240-8. PubMed ID: 10762560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain.
    Hannant D; Jessett DM; O'Neill T; Dolby CA; Cook RF; Mumford JA
    Res Vet Sci; 1993 May; 54(3):299-305. PubMed ID: 8393207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An M2 Rather than a T
    Lee DH; Ghiasi H
    J Virol; 2018 May; 92(10):. PubMed ID: 29491152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent HSV-1 infection in mice immunized with a zwitterionic detergent-extracted HSV-1 antigen preparation.
    al-Ghamdi A; Jennings R; Bentley H; Potter CW
    Arch Virol; 1989; 108(1-2):19-31. PubMed ID: 2556982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus.
    Ben Ahmeida ET; Jennings R; Erturk M; Potter CW
    Arch Virol; 1992; 125(1-4):71-86. PubMed ID: 1642561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation.
    Rajcáni J; Sabó A; Mucha V; Kostál M; Compel P
    Acta Virol; 1995 Feb; 39(1):37-49. PubMed ID: 7572468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical characterization of herpes simplex virus type-1-immunostimulating complexes (ISCMOs): a multi-glycoprotein structure.
    Erturk M; Jennings R; Phillpotts RJ; Potter CW
    Vaccine; 1991 Sep; 9(9):668-74. PubMed ID: 1659055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of HSV-1 ISCOM vaccine in the guinea-pig model of HSV-2 infection.
    Erturk M; Phillpotts RJ; Welch MJ; Jennings R
    Vaccine; 1991 Oct; 9(10):728-34. PubMed ID: 1661978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses.
    Hu KF; Elvander M; Merza M; Akerblom L; Brandenburg A; Morein B
    Clin Exp Immunol; 1998 Aug; 113(2):235-43. PubMed ID: 9717973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge.
    Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
    Antiviral Res; 1995 Oct; 28(2):147-57. PubMed ID: 8585768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection.
    Foster CS; Sandstrom IK; Wells PA; Thompson P; Daigle J; Opremcak EM
    Curr Eye Res; 1988 Nov; 7(11):1051-61. PubMed ID: 2854037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.